virus
major
threat
human
health
signific
effort
made
last
centuri
prevent
treat
viral
diseas
huge
success
develop
potent
safe
afford
viral
human
veterinari
vaccin
use
egg
cellbas
product
system
aubrit
et
al
genzel
barrett
et
al
volz
sutter
addit
novel
approach
toward
vaccin
develop
ie
dna
rna
vaccin
kutzler
weiner
de
gregorio
rappuoli
ahm
et
al
addit
variou
virus
hiv
iav
herp
viru
potent
antivir
avail
treatment
eg
influenza
viru
samson
et
al
simonsen
et
al
despit
signific
challeng
remain
one
hand
human
constantli
challeng
new
virus
includ
zika
viru
merscoronaviru
ebola
viru
hand
virus
chang
rapidli
face
select
pressur
emerg
antivir
drug
resist
major
concern
eg
influenza
viru
samson
et
al
lackenbi
et
al
shin
seong
challeng
partli
address
exist
technolog
sinc
develop
new
vaccin
adapt
exist
manufactur
process
identif
new
antivir
target
time
consum
costli
process
involv
complex
decis
regard
select
effici
product
system
potenc
safeti
aspect
comprehens
clinic
trial
moreov
convent
antivir
measur
may
slow
save
live
case
rapidli
spread
viru
unconvent
option
prevent
viru
spread
cure
infecti
diseas
use
virus
concern
especi
defect
interf
particl
dip
virus
suppress
spread
intact
replic
compet
counterpart
reduc
infecti
viru
yield
five
order
magnitud
eg
akkina
et
al
frens
et
al
dip
alreadi
identifi
earli
fifti
studi
von
magnu
von
magnu
perform
undilut
serial
passag
iav
dip
character
delet
viral
genom
prevent
synthesi
protein
essenti
viral
spread
nayak
et
al
dimmock
easton
frens
replic
dip
reli
presenc
homolog
helper
viru
refer
standard
viru
stv
suppli
miss
viral
protein
tran
interestingli
presenc
dip
demonstr
almost
everi
viru
studi
huang
baltimor
make
dip
viabl
option
prevent
andor
treat
larger
number
viral
diseas
initi
studi
suggest
dip
suppress
stv
replic
may
thu
potenti
protect
viral
diseas
late
eighti
research
start
systemat
exploit
approach
dimmock
et
al
dimmock
colleagu
dimmock
et
al
demonstr
use
molecular
clone
technolog
enabl
gener
dip
potenti
protect
anim
iav
infect
also
show
dip
isol
name
influenza
apuerto
contain
singl
delet
segment
code
suitabl
therapeut
prophylact
protect
anim
lethal
challeng
pandem
iav
potenti
respiratori
virus
duhaut
dimmock
easton
et
al
scott
et
al
dimmock
et
al
dimmock
easton
show
product
antivir
candid
realiz
egg
follow
ultraviolet
uv
irradi
process
destroy
stv
infect
dimmock
et
al
recent
vitro
vivo
antivir
effect
demonstr
combin
three
defect
interf
gene
iav
avian
season
influenza
use
dualfunct
peptid
vector
zhao
et
al
despit
increas
interest
potenti
use
dip
antivir
agent
rel
littl
known
regard
spread
accumul
cell
popul
also
appli
larg
scale
manufactur
dip
biopharmaceut
industri
fertil
chicken
egg
anim
cell
cultur
technolog
could
consid
effici
larg
scale
dip
product
egg
success
use
product
dip
rel
small
amount
dimmock
marriott
dimmock
et
al
cell
culturebas
technolog
less
explor
sever
addit
advantag
larg
scale
dip
manufactur
firstli
anim
cell
ideal
indepth
investig
intracellular
dip
replic
releas
celltocel
spread
control
welldefin
cultiv
condit
bioreactor
extend
time
period
secondli
cell
could
specif
design
dip
gener
ozawa
et
al
bdeir
et
al
yamagata
et
al
use
plasmid
revers
genet
hoffmann
et
al
would
allow
overcom
need
infecti
helper
viru
dip
replic
dip
prepar
contrast
eggbas
product
system
would
contamin
stv
would
need
uv
inactiv
use
antivir
dimmock
et
al
final
variou
quantit
assay
avail
detail
character
dynam
viru
titer
dip
copi
number
togeth
use
specif
stain
method
flow
cytometri
monitor
progress
infect
cell
frens
et
al
swick
et
al
mathemat
model
dip
stv
replic
establish
describ
basic
dynam
cell
cultur
frens
et
al
akpinar
et
al
b
lask
et
al
liao
et
al
studi
follow
gener
idea
describ
frens
et
al
investig
dip
product
continu
cultiv
system
frens
et
al
demonstr
continu
influenza
viru
product
cascad
two
stir
tank
bioreactor
show
oscil
viru
cell
concentr
due
presenc
dip
contrast
approach
use
two
vessel
use
one
bioreactor
continu
cell
product
cell
bioreactor
cb
feed
two
bioreactor
viru
propag
viru
bioreactor
viru
bioreactor
oper
parallel
allow
headtohead
comparison
viru
seed
media
cell
line
chang
cultiv
paramet
condit
close
possibl
start
point
impact
resid
time
rt
h
dip
stv
dynam
investig
regard
establish
manufactur
process
dip
product
mdck
suspens
cell
line
grow
fulli
defin
medium
use
lohr
et
al
viru
seed
contain
known
amount
dip
stv
gener
use
revers
genet
approach
hoffmann
et
al
cultiv
perform
period
day
two
rt
allow
least
two
oscil
stv
dip
replic
dynam
frens
et
al
process
monitor
model
develop
cell
concentr
infecti
noninfecti
viru
titer
well
extracellular
copi
number
stv
ie
fulllength
fl
known
form
dip
determin
base
newli
avail
quantit
data
obtain
dip
stv
concentr
mathemat
model
develop
frens
et
al
extend
fit
basic
process
dynam
rt
describ
well
simul
particular
simul
captur
oscil
process
variabl
eg
viru
titer
addit
model
predict
dynam
cell
subpopul
uninfect
diponli
infect
stvonli
infect
coinfect
cell
canin
cell
line
contact
prof
klau
scharfenberg
univers
appli
scienc
emdenl
germani
cultiv
chemic
defin
medium
gibco
thermo
fischer
scientif
usa
supplement
glutamin
pyruv
mm
final
concentr
sigma
usa
cell
grown
shake
flask
passag
describ
lohr
et
al
influenza
apuerto
viru
seed
contain
dip
delet
ie
gener
revers
genet
use
plasmidsystem
hoffmann
et
al
duhaut
dimmock
viru
seed
refer
therefor
rna
isol
influenza
apuerto
nation
institut
biolog
standard
control
nibsc
respect
cdna
clone
vector
provid
erich
hoffmann
robert
g
webster
st
jude
children
research
hospit
memphi
tn
usa
hoffmann
et
al
result
plasmid
plasmid
carri
defect
sequenc
previous
describ
dimmock
et
al
obtain
clone
respect
sequenc
vector
addit
phw
plasmid
carri
fl
segment
use
also
provid
erich
hoffmann
robert
g
webster
one
day
transfect
cell
seed
mm
dish
prior
infect
cell
wash
pb
ml
optimem
gibco
ad
transfect
perform
simultan
nine
plasmid
ng
use
lipofectamin
ltx
plu
reagent
life
technolog
accord
manufactur
instruct
lipofectamin
ltx
per
dish
increas
amount
viru
particl
adher
mdck
cell
ad
h
posttransfect
h
cell
wash
pb
medium
replac
dmem
gibco
contain
unitsml
trypsin
gibco
sterilefilt
stock
solut
prepar
pb
uml
store
subsequ
cell
incub
addit
h
result
viru
seed
contain
stv
titer
virionsml
ha
titer
ha
obtain
note
segmentspecif
revers
transcriptionquantit
pcr
qpcr
determin
copi
number
viru
seed
bias
sinc
contamin
plasmid
carri
di
sequenc
low
multipl
infect
moi
cultiv
continu
cultur
relev
plasmid
outdilut
see
next
step
viru
seed
infect
suspens
mdck
cell
bioreactor
gener
therefor
viru
seed
passag
suspens
cell
moi
viru
harvest
h
post
infect
pi
clarifi
centrifug
g
supernat
aliquot
result
viru
bank
ha
titer
ha
titer
virionsml
fl
content
copiesml
di
content
copiesml
addit
viru
seed
probe
remain
plasmid
revers
genet
prepar
qpcr
could
bia
revers
transcriptionqpcr
data
fl
di
measur
quantit
pcr
data
show
initi
plasmid
contamin
fl
howev
zero
h
pi
plasmid
contamin
detect
longer
sinc
viru
prepar
dilut
due
low
moi
appli
infect
moi
experi
perform
laboratori
biolog
safeti
level
bsl
certif
follow
respect
safeti
regul
continu
bioreactor
system
consist
three
stir
tank
bioreactor
str
dasgip
use
figur
first
l
str
head
space
capac
ml
work
volum
use
cell
propag
cb
two
l
str
run
parallel
use
viru
propag
inocul
cell
viabl
cellsml
cb
oper
batch
mode
first
h
ml
work
volum
wv
simultan
inocul
viabl
cellsml
grown
batch
mode
ml
wv
ml
wv
respect
work
volum
chosen
achiev
rt
h
respect
use
flow
rate
f
describ
figur
rt
wvf
choic
h
rt
motiv
similar
experi
perform
previous
group
frens
et
al
h
rt
select
base
scout
experi
perform
shake
flask
preliminari
mathemat
simul
shown
cb
maintain
ml
wv
cultiv
paramet
ph
stir
speed
rpm
aerat
control
dissolv
oxygen
partial
pressur
puls
addit
mixtur
air
oxygen
nitrogen
dip
tube
infect
dipcontain
viru
seed
ad
moi
base
viabl
cell
count
titer
viru
seed
h
cultur
addit
viru
inoculum
supplement
ratio
trypsin
volum
cultur
volum
avoid
fast
washout
viru
seed
continu
mode
initi
h
pi
flow
rate
depict
figur
run
trypsin
unitsl
present
feed
medium
viru
bioreactor
feed
media
three
reactor
provid
l
bottl
chill
feed
medium
cell
bioreactor
refil
runtim
sampl
taken
twice
day
day
cb
everi
h
viru
harvest
reservoir
store
analysi
experi
termin
day
pi
averag
cell
concentr
input
cellsml
determin
averag
viabl
cell
count
cb
respect
str
work
volum
feed
rate
rt
determin
averag
volum
averag
flow
rate
outlet
str
infect
phase
viabl
cell
concentr
determin
use
vicellxr
beckman
coulter
viru
product
monitor
hemagglutin
ha
assay
kalbfuss
et
al
assay
genzel
reichl
maximum
standard
deviat
ha
assay
ha
dilut
error
assay
genzel
et
al
furthermor
determin
concentr
total
viru
particl
cv
supernat
base
ha
valu
use
follow
equat
ceri
denot
concentr
chicken
erythrocyt
solut
ad
assay
cellsml
analyz
viral
genom
bioreactor
sampl
centrifug
min
g
viral
rna
isol
supernat
use
nucleospin
rna
viru
kit
machereynagel
accord
manufactur
instruct
revers
transcript
isol
rna
cdna
segmentspecif
amplif
iav
genom
perform
describ
previous
frens
et
al
revers
transcriptionpcr
product
directli
analyz
agaros
gel
use
electrophoresi
see
data
sheet
figur
absolut
viral
rna
vrna
copi
number
determin
describ
previous
wasik
et
al
brief
seri
dilut
correspond
vrna
refer
standard
rna
sampl
revers
transcrib
tag
primer
atttaggtgacactatagaagcgagcgaaagcaggtcaattatattc
subsequ
qpcr
perform
use
rotorgen
sybr
green
pcr
kit
qiagen
follow
manufactur
recommend
primer
pair
realtimerev
ggaatcccctcagtcttc
vrnatagrealtimefor
atttaggtgacactatagaagcg
quantif
primer
pair
catttcatcctaagtgctgg
vrnatagrealtimefor
quantif
fl
viral
rna
copi
number
calcul
base
vrna
refer
standard
linear
regress
lowest
concentr
allow
quantif
copiesml
copiesml
fl
respect
wasik
et
al
rel
standard
deviat
determin
copi
number
qpcr
fl
respect
quantif
contamin
plasmid
perform
dilut
seri
correspond
plasmid
describ
without
revers
transcript
step
plasmid
quantifi
primer
pair
phwf
ctcactatagggagaccc
plasmid
quantifi
primer
pair
realtimerev
phwf
sinc
number
genom
copi
directli
translat
number
viru
particl
adjust
qpcr
measur
fl
assum
sum
contain
virion
fl
virion
denot
maximum
number
virion
present
sampl
equal
concentr
total
viru
particl
cv
base
cv
calcul
concentr
virion
contain
either
fl
use
equat
respect
furthermor
differenti
infecti
fl
virion
vs
noninfecti
fl
virion
vd
made
sinc
know
number
vs
ie
titer
easili
determin
number
noninfecti
fl
virion
solv
equat
vd
base
quantit
data
avail
revers
transcriptionqpcr
encod
iav
establish
recent
group
segreg
mathemat
model
describ
continu
viru
product
system
establish
frens
et
al
modifi
extend
model
version
describ
explicitli
dynam
replicationincompet
virion
dip
contain
delet
vddi
describ
see
materi
method
addit
noninfecti
virion
vd
infecti
virion
vs
contain
fl
anoth
modif
infect
uninfect
target
cell
consid
separ
vs
vddi
account
dip
entri
subsequ
dip
replic
case
coinfect
denot
specif
cell
growth
rate
kvi
kvidi
specif
viru
infect
rate
infecti
stv
dip
respect
last
term
equat
account
continu
feed
cell
concentr
tin
dilut
rate
set
adjust
two
differ
rt
viru
reactor
see
tabl
respect
averag
concentr
cell
observ
cb
choos
tin
independ
time
data
shown
ideal
mix
assum
vessel
popul
infect
cell
subdivid
cell
infect
infecti
stv
dip
id
ic
first
term
equat
account
infect
target
cell
infecti
stv
dip
respect
furthermor
coinfect
id
dip
infecti
stv
respect
yield
coinfect
cell
ic
equat
antivir
mechan
interferonmedi
innat
immun
respons
virusinduc
cell
death
trigger
presenc
intracellular
viral
rna
experi
uptak
high
number
dip
dip
per
cell
result
high
number
intracellular
viral
rna
compar
level
reach
convent
infect
eg
frens
et
al
therefor
contrast
frens
et
al
assum
diponli
infect
cell
id
continu
grow
shutoff
essenti
pathway
cell
divis
similar
infect
cell
popul
ic
thu
die
due
virusinduc
apoptosi
specif
rate
kcdv
note
cane
colleagu
shown
diponli
infect
mdck
cell
continu
grow
give
rise
dipinfect
daughter
cell
cane
et
al
howev
experiment
condit
appli
studi
ie
use
uvirradi
viru
seed
passag
cell
virusfre
cultur
cultur
time
day
passag
compar
cultiv
condit
system
dynam
infecti
stv
vs
dip
vddi
noninfecti
virion
contain
fl
vd
describ
similar
frens
et
al
assum
stvinfect
cell
produc
infecti
stv
vs
specif
rate
also
potenti
releas
dip
vddi
specif
rate
although
analysi
close
zero
see
tabl
latter
ignor
allow
de
novo
gener
dip
case
dipfre
viru
seed
would
use
infect
bioreactor
coinfect
cell
releas
mainli
dip
contain
delet
vddi
specif
rate
addit
stvinfect
coinfect
cell
releas
noninfecti
viru
particl
vd
rate
respect
furthermor
assum
stv
taken
uninfect
cell
diponli
infect
cell
dip
either
infect
uninfect
cell
cell
alreadi
infect
infecti
stv
final
assum
stv
lose
infect
specif
inactiv
rate
kdvit
contribut
popul
noninfecti
virion
vd
vddi
vd
deterior
specif
lysi
rate
kdvt
contrast
previou
model
frens
et
al
neglect
superinfect
ic
stv
well
superinfect
id
ic
dip
investig
time
cours
dip
format
base
revers
transcriptionqpcr
measur
follow
dip
stv
ratio
determin
experiment
data
vddi
repres
revers
transcriptionqpcr
measur
vs
infecti
virion
fl
respect
addit
describ
overal
cell
growth
dynam
concentr
cell
cellstot
viru
bioreactor
estim
taken
togeth
model
compris
seven
ordinari
differenti
equat
set
ten
paramet
tabl
determin
minim
leastsquar
predict
error
state
variabl
vs
vddi
vd
cellstot
error
variabl
weight
maximum
measur
valu
model
equat
solv
numer
use
cvode
routin
sundial
cohen
hindmarsh
linuxbas
system
model
file
experiment
data
handl
within
system
biolog
toolbox
schmidt
jirstrand
matlab
version
paramet
valu
estim
use
global
stochast
optim
algorithm
fssm
egea
et
al
initi
valu
select
base
previou
paramet
determin
iav
replic
anim
cell
eg
frens
et
al
coeffici
variat
paramet
determin
use
copasi
hoop
et
al
mathemat
model
use
present
studi
loos
base
previous
publish
model
frens
et
al
modif
explain
section
materi
method
fit
paramet
model
two
set
experiment
data
determin
coeffici
variat
cov
use
copasi
tabl
rt
h
low
cov
reach
paramet
estim
specif
growth
rate
differ
viral
subpopul
vddi
vs
vd
releas
either
coinfect
cell
ic
stvinfect
cell
respect
similarli
cov
estim
rt
h
specif
stv
infect
rate
kvi
rt
h
well
specif
dip
infect
rate
kvidi
specif
apoptosi
rate
kcdv
rt
h
estim
higher
cov
valu
cov
interestingli
specif
infect
rate
stv
kvi
rt
h
estim
cov
remain
paramet
estim
cov
particular
specif
de
novo
gener
rate
dip
high
cov
experiment
scenario
sinc
dip
present
seed
viru
de
novo
gener
could
also
exclud
model
assumpt
viral
dynam
would
still
show
oscil
due
amplif
dip
introduc
infect
contrast
dipfre
viru
seed
would
use
start
infect
oscil
viral
dynam
could
reproduc
de
novo
gener
account
thu
decid
keep
paramet
propos
model
cover
gener
case
specif
product
rate
noninfecti
fl
virion
could
also
neglect
sinc
particl
like
releas
stvinfect
cell
support
reason
cov
valu
specif
vd
product
rate
rt
h
experi
addit
high
cov
valu
estim
specif
viru
inactiv
lysi
rate
kdvit
kvdt
indic
mechan
probabl
neglect
also
analyz
detail
respect
differ
rt
see
section
model
reduct
overal
key
paramet
valu
estim
studi
specif
stv
infect
rate
kvi
viru
releas
rate
apoptosi
rate
kcdv
viru
degrad
rate
order
magnitud
determin
previous
iav
replic
model
propos
adher
mdck
cell
et
al
schulzehorsel
et
al
heldt
et
al
first
mdck
suspens
cell
seed
grown
batch
mode
simultan
three
bioreactor
cb
figur
cb
set
work
volum
ml
cell
grown
batch
mode
cell
concentr
cellsml
viabil
reach
infect
vessel
work
volum
ml
ml
respect
seed
similar
concentr
howev
reach
cellsml
cellsml
time
infect
respect
infect
took
place
h
cultur
moi
left
batch
mode
anoth
h
initi
continu
mode
avoid
viru
washout
vessel
oper
rt
h
respect
rt
adjust
use
constant
feed
mlh
cell
broth
cb
mlh
fresh
medium
viru
bioreactor
furthermor
maintain
wv
mlh
harvest
vb
averag
concentr
target
cell
transfer
cb
vb
tin
cellsml
upon
paramet
estim
simul
cell
popul
dynam
viru
vessel
show
oscil
uninfect
target
cell
variou
infect
cell
popul
rt
rt
h
figur
although
total
cell
concentr
vb
remain
stabl
averag
cellsml
standard
deviat
cellsml
rt
cellsml
standard
deviat
cellsml
rt
h
tendenc
toward
cyclic
behavior
observ
figur
b
link
simul
dynam
variou
cell
popul
caus
viru
propag
expect
addit
viru
seed
caus
fast
increas
stvonli
infect
cell
follow
strong
drop
concentr
simultan
increas
coinfect
cell
popul
superinfect
dip
figur
coinfect
cell
popul
reach
maxima
day
pi
day
pi
rt
h
respect
sinc
coinfect
cell
releas
mainli
dip
uninfect
target
cell
fed
vb
infect
dip
diponli
infect
cell
popul
reach
peak
concentr
day
pi
rt
h
day
pi
rt
h
popul
coinfect
cell
undergo
virusinduc
apoptosi
ceas
minimum
figur
howev
number
coinfect
cell
rise
quickli
sinc
previous
diponli
infect
cell
superinfect
stv
produc
small
subpopul
stvonli
infect
cell
behavior
repeat
anoth
cycl
within
cultiv
time
therebi
subpopul
infect
cell
reach
peak
concentr
repeatedli
similar
vb
thu
seem
independ
rt
overal
variat
measur
cell
concentr
vb
follow
oscil
trend
describ
similar
experi
frens
et
al
use
avian
cell
line
infect
iav
apuerto
moi
rt
h
inde
qualit
quantit
discrep
model
simul
measur
total
cell
concentr
one
hand
count
mdck
suspens
cell
requir
addit
trypsin
dissoci
cell
aggreg
occur
occasion
increas
risk
outlier
cell
concentr
measur
hand
model
wellinform
dynam
variou
infect
cell
subpopul
sinc
measur
focus
viral
dynam
see
follow
section
viral
dynam
better
resolv
issu
followup
studi
plan
investig
detail
dynam
variou
cell
popul
use
flow
cytometri
ideal
would
involv
convent
monitor
infect
cell
use
iavspecif
antibodi
frens
et
al
use
fluoresc
marker
specif
intracellular
label
di
rna
current
avail
develop
allow
distinguish
coinfect
stvonli
infect
cell
revers
transcriptionqpcr
measur
enabl
monitor
fl
di
copi
number
togeth
concentr
total
number
viru
particl
ha
titer
titer
figur
allow
discrimin
variou
viru
subpopul
use
valu
calcul
concentr
virion
contain
either
fl
di
base
qpcr
measur
given
copiesml
virionsml
see
equat
overal
viral
titer
fl
di
virion
show
trend
two
rt
test
first
day
cultur
figur
maximum
concentr
fl
virion
virionsml
virionsml
reach
day
pi
rt
h
respect
figur
b
rt
h
titer
slowli
decreas
virionsml
day
pi
higher
rt
decreas
titer
fl
virion
delay
compar
rt
reach
minimum
virionsml
day
pi
time
vb
rt
h
alreadi
reach
second
peak
follow
decreas
titer
lead
second
minimum
day
pi
second
minimum
rt
h
reach
day
later
concentr
di
virion
show
initi
delay
cycl
day
compar
correspond
fl
counterpart
reach
first
maxima
virionsml
day
pi
virionsml
day
pi
rt
h
respect
figur
cyclic
trend
observ
data
set
describ
clearli
model
fit
note
quantit
discrep
data
model
simul
remain
underestim
fl
viru
titer
variou
time
point
figur
b
although
measur
simul
viru
titer
show
discrep
individu
run
simul
mainli
within
error
rang
assay
ha
log
log
regard
error
number
virion
contain
either
fl
di
consid
deriv
qpcr
measur
rel
standard
deviat
ha
titer
equat
nevertheless
investig
eg
nextgener
deep
sequenc
perform
elucid
discrep
detail
time
cours
infecti
virion
vs
measur
assay
sum
viral
subpopul
determin
ha
assay
vsvdvddi
also
show
pronounc
oscil
figur
furthermor
ha
data
indic
trend
overal
decreas
amplitud
titer
toward
later
cultiv
time
point
rt
figur
titer
reach
maxima
initi
peak
follow
peak
titer
lower
howev
overal
decreas
peak
infecti
titer
observ
figur
b
maximum
titer
achiev
around
day
pi
virionsml
virionsml
rt
h
respect
like
higher
infecti
titer
longer
rt
h
relat
reduc
washout
lower
dilut
rate
compar
rt
h
total
three
cycl
observ
short
rt
second
third
peak
virionsml
day
pi
respect
figur
similar
behavior
observ
rt
h
howev
cycl
achiev
cultiv
time
figur
dynam
captur
well
quantit
qualit
simul
measur
ha
valu
deviat
certain
extent
within
assay
error
rang
data
point
day
pi
figur
particular
decreas
trend
peak
ha
titer
reproduc
model
also
case
system
simul
day
pi
data
sheet
figur
whether
decreas
trend
peak
ha
titer
individu
characterist
particular
run
model
simul
still
lie
within
biolog
variat
experi
need
address
experi
becom
avail
sinc
overal
goal
studi
establish
fit
basic
model
minimum
number
paramet
simpl
kinet
decid
keep
model
structur
like
also
detail
studi
regard
dynam
individu
cell
popul
allow
improv
model
see
discuss
cellular
dynam
expect
oscil
also
observ
dynam
dip
stv
ratio
figur
cultiv
ratio
reach
maximum
day
pi
maxima
similar
rt
correl
lowest
titer
may
hypothes
one
infecti
stv
per
dip
critic
ratio
dip
caus
selfinterfer
start
hamper
overal
viru
replic
significantli
impact
high
dip
stv
ratio
relat
selfinterfer
support
model
studi
group
lask
et
al
consequ
selfinterfer
dip
concentr
decreas
reach
minimum
around
day
pi
number
infecti
stv
rise
initi
new
cycl
see
also
figur
would
interest
test
whether
critic
ratio
reproduc
experi
continu
twostag
cultiv
fit
present
model
model
data
set
test
could
still
describ
data
certain
paramet
remov
first
set
paramet
inactiv
vs
kdvit
lysi
rate
virion
kvdt
zero
refit
model
model
data
set
rt
h
good
fit
similar
full
model
model
visual
figur
quantit
base
object
function
valu
tabl
expect
sinc
paramet
kdvit
kvdt
alreadi
close
zero
model
second
data
set
rt
h
refit
model
result
notic
increas
object
function
valu
tabl
addit
model
unabl
describ
data
qualit
particular
number
cycl
viral
dynam
could
reproduc
figur
like
point
import
featur
cultiv
long
rt
degrad
inactiv
process
taken
explicitli
account
adequ
describ
data
contrast
cultiv
short
rt
higher
dilut
rate
overal
impact
washout
virion
viral
dynam
probabl
higher
inactiv
degrad
process
next
test
whether
essenti
account
separ
specif
rate
infect
either
stv
kvi
dip
infect
kvidi
use
model
defin
one
joint
infect
rate
kvi
model
upon
fit
model
data
rt
h
overal
dynam
still
describ
well
howev
model
overestim
titer
underestim
number
fl
di
virion
well
overal
number
virion
produc
figur
observ
similar
effect
rt
h
data
set
combin
lower
number
cycl
compar
fit
model
figur
suggest
two
separ
infect
rate
need
achiev
good
agreement
experiment
data
although
visual
good
fit
model
data
set
seem
better
model
object
function
valu
decreas
compar
model
rt
h
tabl
rt
h
tabl
respect
first
glanc
decreas
object
function
valu
seem
counterintuit
howev
sinc
model
still
good
agreement
major
measur
state
variabl
eg
dip
concentr
figur
object
function
valu
might
compar
model
fit
oscil
data
set
experienc
object
function
valu
mislead
paramet
regim
instanc
optim
may
also
yield
good
quantit
fit
straight
line
mean
experiment
data
final
also
test
fourth
version
model
consist
combin
model
model
ie
neglect
viru
degrad
process
use
joint
infect
rate
simultan
case
rt
h
model
follow
dynam
model
figur
expect
sinc
analysi
model
alreadi
show
degrad
process
highli
relev
rt
h
thu
model
model
mechanist
ident
also
lead
similar
parametr
two
model
tabl
rt
h
dynam
model
similar
model
show
fewer
cycl
due
exclus
viru
inactiv
degrad
process
figur
addit
model
show
quantit
deviat
similar
model
togeth
underlin
import
viru
inactiv
degrad
process
well
separ
dip
stv
infect
rate
rt
h
taken
account
captur
experiment
data
like
differ
kvi
kvidi
relat
underli
mass
action
kinet
model
sinc
dip
concentr
averag
two
order
magnitud
higher
stv
concentr
model
estim
lower
specif
dip
infect
rate
yield
adequ
amount
diponli
coinfect
cell
high
dip
titer
supernat
whether
biolog
background
still
need
address
experiment
ideal
model
includ
parametr
allow
predict
viral
dynam
differ
rt
eg
perform
modelbas
process
optim
howev
due
mechan
seem
depend
rt
explain
none
current
modelparametercombin
abl
predict
viral
dynam
rt
vice
versa
see
also
data
sheet
figur
accordingli
think
model
might
still
lack
certain
aspect
kinet
therefor
room
model
extens
instanc
includ
eclips
phase
ie
time
delay
viru
infect
releas
viral
progeni
take
account
accumul
di
rna
except
might
help
improv
model
fit
enabl
predict
see
data
sheet
figur
present
studi
introduc
twostag
continu
bioreactor
setup
headtohead
comparison
iav
dip
product
differ
cultur
condit
infect
use
viru
seed
gener
revers
genet
contain
known
dip
enabl
monitor
di
fl
viru
replic
base
qpcr
measur
observ
oscil
viral
titer
frequenc
depend
rt
ie
increas
rt
h
caus
shift
cycl
day
pcr
analysi
iav
segment
reveal
chang
rt
might
also
result
accumul
differ
dip
subpopul
longterm
cultur
mathemat
model
establish
allow
describ
time
cours
variou
viral
cellular
subpopul
comparison
model
fit
two
data
set
obtain
suggest
longer
rt
h
inactiv
infecti
stv
degrad
virion
taken
account
interestingli
good
fit
also
affect
addit
assumpt
dip
stv
infect
cell
differ
rate
still
observ
discrep
model
experiment
data
found
predict
power
model
need
improv
may
relat
fact
model
still
fulli
inform
eg
regard
dynam
differ
infect
cell
subpopul
de
novo
synthesi
impact
dip
except
addit
model
might
extend
account
eclips
phase
viru
releas
use
report
virus
specif
probe
di
rna
stain
may
help
elucid
mechan
detail
paramet
estim
use
data
set
one
parallel
run
therefor
unabl
evalu
good
fit
respect
biolog
variat
cultiv
address
futur
cultiv
perform
similar
experiment
condit
becom
avail
summari
continu
cultiv
system
establish
excel
tool
detail
studi
regard
dip
replic
anim
cell
base
high
dip
concentr
obtain
also
qualifi
system
product
dip
anim
trial
influenza
antivir
therapi
dataset
gener
studi
includ
manuscriptsupplementari
file
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
